Genomenon, Inc. is an AI-driven genomic intelligence company based in Ann Arbor, Michigan. The company focuses on organizing genomic knowledge to identify the causes of genetic diseases and cancer, facilitating actionable insights for patient diagnosis and precision medicine. With a team of 51-200 employees and approximately $42 million in revenue, Genomenon combines AI technology with genomic expertise to simplify complex data and enhance clinical decision-making.
The company's flagship product, the Mastermind® Genomic Intelligence Platform, offers AI-powered insights for germline and somatic variant interpretation. Additionally, the Cancer Knowledgebase (CKB) provides a specialized database for somatic mutations in cancer, linking variants to therapies and clinical trials. Genomenon also offers expert consulting services, including custom variant analysis and regulatory guidance, along with continually updated genomic data for integration into client systems. The company has received recognition for its contributions to clinical genomics and has established partnerships to further enhance its offerings.
Ann Arbor, United States of AmericaHealthcareOtherMidsize